EPISODE · Jun 25, 2020 · 8 MIN
S1 Ep6: ARVO 2020: Two-year anatomical outcomes of FAc in DME patients
from EyePod · host Ophthalmology Times
Victor Gonzalez, MD, speaks with Ophthalmology Times® David Hutton on the highlights of his presentation regarding "Two-year outcomes from the PALADIN Phase 4 study: Anatomic/functional changes and reduced treatment frequency associated with 0.19 mg of fluocinolone acetonide implant (FAc) with persistent or recurrent diabetic macular edema," during the 2020 Association for Research in Vision and Ophthalmology (ARVO) virtual meeting.
Embed this episode
NOW PLAYING
S1 Ep6: ARVO 2020: Two-year anatomical outcomes of FAc in DME patients
No transcript for this episode yet
Similar Episodes
No similar episodes found.